Reimbursement

A fresh stream of data is raising some concerns about a new class of diabetes medicines and their relation to long-term heart health.

We are now in the Golden Age of government-sponsored health programs, and the opportunities and challenges that come with this shift have never been greater.

UnitedHealthcare is testing the waters of consumer rewards and digital engagement, in a new partnership with Walgreens that's aiming to spur better health choices.

A sustainable Medicare payment for home-based medicine is on the horizon, and some insurers are already major backers of the service. But health plans could be doing more, especially in Medicare Advantage.

Challenging Highmark's cuts to cancer payments, UPMC is playing the long-game in being the provider of choice for western Pennsylvania's seniors.

Despite some lulls, the war between the University of Pittsburgh Medical Center and Highmark is again raging, now with a battle over Medicare Advantage plans and oncology reimbursement.

How far can private exchanges go? New data suggest a large migration is in the works, even as the model brings some uncertainties for employers and insurers.

To fix financial woes, New York City's taxpayer-owned health system is plotting a comeback and planning to give more residents a kind of public option for health insurance.

As consumers increasingly are being asked to pay a larger share of their health bills, a coalition of insurers, pharmaceutical companies and provider and consumer advocacy groups launched a new push for greater transparency about the actual costs of services.

Employer health plans have seen significant benefit design changes in the past few years, due to rising healthcare costs and the Affordable Care Act. As actuaries analyze historical medical cost trend in order to forecast future trends and analyze the impact of benefit design changes, the effect of the member behavioral phenomena known as "benefit rush," "benefit hush" and "trend crush" should be considered.